Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme

Figure 8

GO and KEGG pathway analyses of CD163 in GBM: (a) BP analysis; (b) CC analysis; (c) MF analysis; (d) KEGG pathway analysis.

(a)

(b)

(c)

(d)